E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/12/2005 in the Prospect News PIPE Daily.

New Issue: Life Therapeutics raises A$2.28 million in private placement of stock

By Sheri Kasprzak

Atlanta, May 12 - Life Therapeutics Ltd. said it has closed a private placement of stock for A$2,281,916.

The company sold 4,148,939 shares at A$0.55 each to sophisticated and institutional investors.

Based in New South Wales, Australia, Life Therapeutics is a biotechnology company focused on developing diagnostic testing products. The proceeds will be used for an upcoming acquisition.

Issuer:Life Therapeutics Ltd.
Issue:Stock
Amount:A$2,281,916
Shares:4,148,939
Price:A$0.55
Warrants:No
Settlement date:May 12
Stock price:A$0.66 at close May 12

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.